Related Experiment Videos
Estrogen and progesterone receptor analysis in ocular melanomas
A J Foss1, R A Alexander, M J Guille
1Department of Clinical Science, Institute of Ophthalmology, London, England.
Ophthalmology
|March 1, 1995
Summary
This study found no estrogen or progesterone receptors in ocular melanomas, suggesting these hormones do not drive melanoma development or metastasis. Further research is needed to understand the role of heat-shock protein 27 in these tumors.
Area of Science:
- Ophthalmology
- Oncology
- Endocrinology
Background:
- Hormonal influences on melanoma metastasis, particularly during pregnancy or with contraceptive pill use, are debated.
- Uveal and conjunctival melanomas are rare eye cancers.
- The role of estrogen and progesterone in melanoma progression requires investigation.
Purpose of the Study:
- To determine the expression of estrogen receptors (ER) and progesterone receptors (PgR) in uveal and conjunctival melanomas.
- To investigate the potential role of hormonal factors in the development and progression of ocular melanomas.
Main Methods:
- Immunohistochemistry was performed on 27 choroidal and 5 conjunctival melanomas.
- Antibodies used included ER-D5 (heat-shock protein 27), ER-1D5 (estrogen receptor), and PgR (progesterone receptor).
Main Results:
- Most ocular melanomas expressed heat-shock protein 27.
- No tumors exhibited positive nuclear staining for estrogen receptor (ER) or progesterone receptor (PgR).
Conclusions:
- Estrogen receptor and progesterone receptor expression were not detected in choroidal or conjunctival melanomas.
- Current evidence suggests limited involvement of these hormones in the development or progression of ocular melanomas.